|
|
|
|
|
Session 149
Poster Abstracts Cardiovascular Risk and Disease Friday, 1:30 - 3:30 pm Hall B |
Background: An
increased cardiovascular risk has been suggested in HIV-infected patients since
the availability of highly active antiretroviral therapy (HAART). We wanted to
evaluate the change in carotid intima-media thickness
(IMT), a reliable marker of atherosclerosis, during a 36-month period in a
cohort of HIV-infected patients.
Methods: Patients were included successively from the
Results: A
total of 233 patients were included in the study with a median age of 44 years
at baseline (interquartile range [IR] = 39 to 50), 57
(25%) were women, 138 (59%) were current smokers, and 74 (32%) at the AIDS
stage. Of the total, 200 patients were treated by a HAART regimen, including a
protease inhibitor (PI) for 55%. During the first 12 months, 16 patients were
newly treated by statins (n = 8) or fibrates (n = 8) in relation to their dyslipidemia;
42 had their ART regimen changed to stop the PI; and 10 patients stopped
smoking. During this period, serum triglycerides, HDL, and total cholesterol
levels remained stable overall (p = 0.24,
0.75 and 0.78, respectively). Conversely, the IMT increased from 0.55 to 0.57
mm (p < 10–4). In the
following 24-month period, 52 patients switched from a PI-containing regimen to
PI-free regimens, 30 patients were newly treated with anti-lipid drugs, and 14
stopped smoking, resulting in a point prevalence at month
36 of 17% for patients treated with fibrates or statins, 60% for PI-free ART and 51% for current smokers.
During the same 2-year period, there was a significant decrease of total
cholesterol (p < 10–4),
LDL cholesterol (p = 0.05), and
median IMT, from 0.57 to 0.53 mm (p <
10–4). In unadjusted analyses, there was a single significant
association between smoking cessation and IMT decrease (p < 0.05) but this association disappeared after adjustment (p = 0.45).
Conclusions: The
potential beneficial consequences of interventions for cardiovascular risk
prevention must be confirmed in larger study populations with clinical
outcomes. The potential effect of smoking cessation in particular should
encourage its active promotion in HIV medicine.
Keywords: intima media thickness; atherosclerosis; cardiovascular risk
![]() |